Literature DB >> 7599933

The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia.

S G Sydserff1, A J Cross, K J West, A R Green.   

Abstract

1. The effect of chlormethiazole has been studied in a transient middle cerebral artery (MCA) occlusion model of cerebral ischaemia in the rat. The MCA was occluded for 1 h by use of an intraluminal suture technique, with reperfusion for 24 h following removal of the occluding filament. Neuronal damage was determined by measurement of the area of necrosis following Cresyl Violet staining of sections taken through the ischaemic region. 2. In the initial experiment, occlusion of the MCA produced a large volume of ischaemic damage in both cortex and striatum, characterized by necrosis and pyknosis (total volume of damage, 287 +/- 13 mm3, n = 9). Rats injected with chlormethiazole (1000 mumol kg-1, i.p.) 60 min before occlusion had a reduced volume of damage in both regions (104 +/- 11 mm3; n = 9; P < 0.001). 3. In a subsequent study systemic physiological parameters (heart rate, blood pressure, blood pH, blood gases and rectal temperature) were measured throughout the ischaemic period. 4. Chlormethiazole (1000 mumol kg-1) pretreatment produced little change in systemic physiology and the neuroprotective effect of the drug when given 60 min prior to the MCA occlusion was confirmed. Chlormethiazole was also neuroprotective when given 10 min following the start of reperfusion (control group: 244 +/- 52 mm3, n = 10; chlormethiazole pretreatment group: 102 +/- 23 mm3, n = 10; P < 0.001; chlormethiazole post-ischaemia group: 122 +/- 16 mm3; P < 0.001, n = 10). 5. It is concluded that chlormethiazole is an effective neuroprotective agent in this model of transient focal ischaemia. The observation that chlormethiazole is protective when given after reperfusion indicates that the effect of the drug is unlikely to be due to an alteration of intra-ischaemic cerebral blood flow, but is more probably a direct effect on the development of ischaemic damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599933      PMCID: PMC1510402          DOI: 10.1111/j.1476-5381.1995.tb14950.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Role for gamma-aminobutyric acid in selective vulnerability in gerbils.

Authors:  L L Sternau; W D Lust; A J Ricci; R Ratcheson
Journal:  Stroke       Date:  1989-02       Impact factor: 7.914

2.  The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia.

Authors:  A Buisson; M Plotkine; R G Boulu
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.

Authors:  A M Buchan; A Slivka; D Xue
Journal:  Brain Res       Date:  1992-03-06       Impact factor: 3.252

4.  Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil.

Authors:  A J Cross; J A Jones; H A Baldwin; A R Green
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

5.  Induction of reproducible brain infarction by photochemically initiated thrombosis.

Authors:  B D Watson; W D Dietrich; R Busto; M S Wachtel; M D Ginsberg
Journal:  Ann Neurol       Date:  1985-05       Impact factor: 10.422

Review 6.  New models of focal cerebral ischaemia.

Authors:  I Mhairi Macrae
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

7.  The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia.

Authors:  R Gill; C Brazell; G N Woodruff; J A Kemp
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

8.  The effects of dizocilpine (MK-801), phencyclidine, and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat.

Authors:  G W Bielenberg; T Beck
Journal:  Brain Res       Date:  1991-06-28       Impact factor: 3.252

9.  The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.

Authors:  C K Park; D G Nehls; D I Graham; G M Teasdale; J McCulloch
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  8 in total

Review 1.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

2.  Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation.

Authors:  Lawren Vandevrede; Ehsan Tavassoli; Jia Luo; Zhihui Qin; Lan Yue; David R Pepperberg; Gregory R Thatcher
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

3.  Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.

Authors:  S G Sydserff; A R Borelli; A R Green; A J Cross
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites.

Authors:  A R Green; T K Murray; A Misra; M F Snape; J A Jones; A J Cross
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity.

Authors:  A J Cross; J A Jones; M Snares; K G Jostell; U Bredberg; A R Green
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.

Authors:  Per-Henrik Zingmark; Marianne Ekblom; Tomas Odergren; Tim Ashwood; Patrick Lyden; Mats O Karlsson; E Niclas Jonsson
Journal:  Br J Clin Pharmacol       Date:  2003-08       Impact factor: 4.335

7.  Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids.

Authors:  P J Hutchinson; M T O'Connell; P G Al-Rawi; C R Kett-White; A K Gupta; L B Maskell; J D Pickard; P J Kirkpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

8.  Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a neuroprotective agent.

Authors:  P J Hutchinson; M T O'Connell; J P Coles; D A Chatfield; M R Coleman; P G Al-Rawi; C R Kett-White; A K Gupta; D K Menon; S J Boniface; M Heazell; P J Kirkpatrick; J D Pickard
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.